1. It played a leading role in non-medical and health assistance.

Chinese pharmaceutical products have gradually entered the African market through assistance to Africa, and have gradually been recognized by ordinary Africans with their high quality and low price, and the brand image has gradually been established.

One is to provide the most direct channel for ordinary people in Africa to come into contact with Chinese pharmaceutical products. China-Africa medical cooperation can be traced back to the first support of non-medical groups in 1963. According to public statistics, China's aid to Africa currently has medical staff in more than 50 countries and regions in Africa, and has treated approximately 270 million African patients. Many high-quality Chinese pharmaceutical products represented by artemisinin have played an important role in the treatment of many African patients through the aid of the African medical team, and they are also well known by the local people.

The second is to establish the brand image of "Teaching people to fish is worse than teaching people to fish" for Sino-African medical cooperation. According to public data, China has assisted in the construction of nearly 30 hospitals and 30 malaria prevention and treatment centers in Africa, provided 800 million yuan in medical equipment and materials and antimalarial drugs, trained more than 3,000 medical staff, and implemented the "African Talent Program." Dispatch 500 maternal and child experts to help African countries reduce maternal mortality and infant mortality. China-Africa medical cooperation has played an important role in enhancing the public health capacity of African countries.

The third is to provide more opportunities for Sino-African medical cooperation to benefit African people. In order to help West African countries fight the Ebola epidemic, China provided assistance totaling RMB 750 million to the affected areas in 2014, and sent more than 1,000 medical personnel and experts to the affected countries, and provided assistance in Sierra Leone and Liberia respectively. The establishment of biosafety laboratories and treatment centers has played an important role in the fight against the Ebola epidemic. Since the outbreak of the new crown epidemic, the Chinese government has provided multiple batches of anti-epidemic material assistance to 53 countries with diplomatic relations and the African Union, dispatched 5 medical expert teams, and 46 medical teams based in Africa have also actively supported local anti-epidemic work. Fang came to China for commercial procurement of medical supplies to provide convenience, and actively implemented the G20 debt relief initiative. In addition, Chinese companies in Africa actively fulfill their social responsibilities and actively donate anti-epidemic materials and money to African countries.

2. China-Africa pharmaceutical trade has played a leading role.

Relatively speaking, China-Africa pharmaceutical trade has low difficulty and quick results, involving the largest number of participating companies, and will still occupy a dominant position at present and for a long period of time in the future.

First, the importance of pharmaceutical trade in bilateral trade has become more prominent. According to statistics, the volume of Sino-African pharmaceutical trade in 2019 increased from approximately US$1.31 billion in 2010 to approximately US$2.931 billion, a year-on-year increase of 20.17%, more than doubled in ten years, much higher than the 2.21% growth rate of Sino-African trade in the same period. According to the latest statistics, from January to June 2020, with the overall decline in Sino-African trade, Sino-African pharmaceutical trade has achieved a counter-trend growth to US$1.602 billion, a year-on-year increase of 13.99%.